Jack Bauer and the Flu

Posted by Robert Flynn on Oct 23, 2015 6:49:12 AM

On February 5, 2015, Public Health England announced that the flu vaccine had demonstrated low effectiveness against the main strain of flu that had circulated this past winter. Dr. Michael Skinner of Imperial College London, said in response, “Trying to predict which seasonal flu vaccine to produce each year must be a bit like a Jack Bauer car chase in Los Angeles…bound to prove somewhat hit & miss.” 

A similar miss occurred in 2004, when the United States suspended The Chiron Corporation’s shipment of 48 million doses of vaccine, citing problems at the company’s Liverpool, England, manufacturing plant.

Read More

Topics: Brand Insights, Market Analysis, Pharma, Scenario Analysis, Healthcare, Life Sciences, Merger and Acquisition

Holiday Gaming - Microsoft's Big Chance

Posted by Robert Flynn on Oct 13, 2015 9:00:00 AM

If Satya Nadella, CEO of Microsoft, has his way, packages under the Christmas tree and exchanged during Chanukah will be full of boxes containing Xbox consoles and games. To increase gaming revenues, he's made some organizational moves assigning Phil Spencer as head of Xbox and Xbox Live, reporting to Windows chief Terry Myerson. But internal changes will not be sufficient in this huge, highly competitive and fast-paced market, especially given Microsoft's slow growth relative to competitors, a laggard performance largely driven by the impact of mobile gaming.

Read More

Topics: Competitive Intelligence, Consumer Goods, Brand Insights, Innovation, Manufacturing/Industrial, Market Analysis, New Market Entry, Scenario Analysis, Technology/Telecomm, Industry Convergence, Merger and Acquisition, Product Positioning, Competitive Strategy

The Tweet Heard ‘Round the Pharmaceutical World: A Perspective On Pharmaceutical Drug Pricing

Posted by Alexis Kuchins on Oct 5, 2015 3:22:18 PM

A week ago, presidential candidate Hillary Clinton tweeted her intentions, if elected, to try to curb the rising costs of pharmaceuticals. The plan would place a monthly cap on the out-of-pocket cost that chronic pain patients would have to pay for prescription medications, a greater emphasis on bringing biotechnology-style drugs to the market, and encourage increased use of generic and imported drugs.

Read More

Topics: Competitive Intelligence, Innovation, Market Analysis, New Market Entry, Pharma, Scenario Analysis, Healthcare, Industry Convergence, Life Sciences, Product Positioning, Competitive Strategy

Companion Diagnostic Strategy: Who Bears Those Costs?

Posted by Alexis Kuchins on Sep 28, 2015 4:25:04 PM

The 2015 World CDx conference in Boston, Massachusetts brought together thought leaders from pharma, diagnostics, and companion diagnostic companies (CDx). This dynamic group of individuals engaged in a dialogue on areas such as next generation sequencing and companion diagnostics, precision medicine, and the regulatory landscape. In conversation with participants and presenters there was a consistent theme of seeking to understand companion diagnostic strategy and who will bear those costs.

Read More

Topics: Competitive Intelligence, Brand Insights, Innovation, Manufacturing/Industrial, Market Analysis, Medical Devices, Pharma, Scenario Analysis, Healthcare, Life Sciences

Automotive Disruption: Fines Doubled in Construction Zone

Posted by Robert Flynn on Sep 23, 2015 1:27:32 PM

While it was a boat that President Obama used to explore the Alaskan scenery, it is the automobile industry that should sit up and take notice. One anticipated result of the President’s trip, and ongoing international negotiations, is increased environmental regulation that would impact automobile manufacturers. Shifting consumer demand, expanding access to customer data, increased merger and acquisition activity and international regulatory changes are creating market uncertainty that needs to be explored and understood through robust scenario-based planning analysis. Shareholders will expect no less.

Read More

Topics: Competitive Intelligence, Consumer Goods, Brand Insights, Innovation, Market Analysis, New Market Entry, Scenario Analysis, Industry Convergence, Merger and Acquisition, Competitive Strategy

Honest lessons from the C-Suite

Posted by Leonard Fuld on Sep 16, 2015 9:14:57 AM

How often do you get down and talk about honest mistakes and irreverent strategies with a CEO?

Over the past year I have had the privilege to interview over a half dozen former CEOs from companies the likes of JP Morgan, Corning, Harrahs/Caesar’s Casinos and Pearson. All companies with a global reach and encountering one challenge or another. I’ve collected these interviews in a special section of this website, C-Suite Candor.

Read More

Topics: Competitive Intelligence, Consumer Goods, Brand Insights, Innovation, Manufacturing/Industrial, Market Analysis, New Market Entry, Scenario Analysis, Technology/Telecomm, Industry Convergence, Merger and Acquisition, Product Positioning, Competitive Strategy

The Post Office’s Business Transformation Strategy: Return to Sender

Posted by Nathaniel Emmons on Aug 27, 2015 10:35:00 AM

As a recent Wall Street Journal article reported, the U.S. Postal Service (USPS) is embarking on a new business strategy and entering the same-day delivery industry. The USPS is ill-equipped to effectively execute on this new competitive strategy and compete in the highly innovative same-day delivery industry. To see why this competitive strategy is ill-conceived, we must examine four key factors.

First, what inherent advantages does the USPS have that will enable it to succeed in the same day delivery market? The USPS has an expansive distribution channel, numerous physical locations, and a sophisticated delivery infrastructure throughout the country. For example, the USPS has 31,662 retail offices nationwide and 211,264 delivery vehicles at its disposal. Clearly, the USPS has the resources to succeed in the same-day delivery industry.

Read More

Topics: Competitive Intelligence, Value Chain Analysis, Brand Insights, Innovation, Market Analysis, Scenario Analysis, Competitive Strategy

Climate Change Proposals Highlight Need for Scenario Planning

Posted by Robert Flynn on Aug 20, 2015 2:47:00 PM

President Obama this week unveiled his plan to cut nationwide carbon dioxide emissions 32 percent by 2030 from 2005 levels. The plan, an attempt to galvanize other countries to achieve a global climate treaty in the short term and to establish the President’s legacy for the long term, has been lauded by some and criticized by others. Despite the President's firm goals, given the opposing applause and uproar, the success of his plan and the impact to the nation's business environment remain hazy.

Read More

Topics: Competitive Intelligence, Manufacturing/Industrial, Scenario Analysis, Competitive Strategy

Amazon Redefines the Grocery Store; the Industry Should Pay Attention

Posted by Robert Flynn on Aug 12, 2015 2:14:10 PM

As a youth, back before mobile phones and customer segmentation, I earned my allowance delivering orders to local customers, from the Mountain Heights corner store, a neighborhood grocery in New Haven, Connecticut. In those days, loyal customers – mostly elderly and all within a few blocks – would use the telephone to place an order for the usual array of soaps, cosmetics, and paper products. I’d earn a half dollar for my efforts. Mountain Heights had its corner of the city, while other grocers serviced their allotted section of the city. An idyllic setting.

Read More

Topics: Competitive Intelligence, Consumer Goods, Brand Insights, Innovation, Market Analysis, Scenario Analysis, Product Positioning, Competitive Strategy, Amazon

Take the new global CI Benchmarking survey (and see your results instantly!)

Posted by Fuld + Company on Aug 5, 2015 9:12:47 AM

How does your CI program compare to other across the globe?

Competitive intelligence (CI) is just over three decades old and plays a critical role in corporate decision making around the world. Join over 700 companies that have participated in this Fuld + Company survey over the past 10 years. By participating in the 2015 benchmark update, you will learn the latest information on CI budgets, reporting relationships, as well as understanding how strategic or how tactical your CI program is compared to others in your industry or in other geographies.

Read More

Topics: Competitive Intelligence, Consumer Goods, War Games, Brand Insights, Fuld + Company, Market Analysis, Pharma, Scenario Analysis, Technology/Telecomm, Life Sciences, Merger and Acquisition

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.